{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T22:11:40Z","timestamp":1762899100458},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Young Research Program of the Italy's Health Minister","award":["GR-2009 \u2013 1524351"],"award-info":[{"award-number":["GR-2009 \u2013 1524351"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Pharmacology"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.coph.2014.12.005","type":"journal-article","created":{"date-parts":[[2014,12,30]],"date-time":"2014-12-30T11:30:16Z","timestamp":1419939016000},"page":"35-42","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["The molecular basis of primary aldosteronism: from chimeric gene to channelopathy"],"prefix":"10.1016","volume":"21","author":[{"given":"Livia","family":"Lenzini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gian Paolo","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.coph.2014.12.005_bib0005","first-page":"204","article-title":"Hypertension caused by tumors of the adrenal cortex","volume":"8","author":"Litynski","year":"1953","journal-title":"Pol Tyg Lek (Wars)"},{"key":"10.1016\/j.coph.2014.12.005_bib0010","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1001\/archinte.1956.00250200011001","article-title":"Aldosterone in clinical medicine; past, present, and future","volume":"97","author":"Conn","year":"1956","journal-title":"AMA Arch Intern Med"},{"key":"10.1016\/j.coph.2014.12.005_bib0015","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/j.jacc.2006.07.059","article-title":"A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients","volume":"48","author":"Rossi","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.coph.2014.12.005_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.ecl.2011.01.005","article-title":"Diagnosis and treatment of primary aldosteronism","volume":"40","author":"Rossi","year":"2011","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.coph.2014.12.005_sbref0025","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1126\/science.1198785","article-title":"K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension","volume":"331","author":"Choi","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.coph.2014.12.005_bib0030","doi-asserted-by":"crossref","first-page":"E1765","DOI":"10.1210\/jc.2014-1927","article-title":"The first novel mutation out of the selectivity filter and the first demonstration of the role of the Na\/Ca exchanger in raising free intracellular calcium","volume":"99","author":"Kuppusamy","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.coph.2014.12.005_bib0035","doi-asserted-by":"crossref","unstructured":"Zheng F, Zhu L, Nie A, Li X, Zhang K, Chen J, Zhou W, Shen Z, Zhu Y, Wang J, et al.: Clinical characteristics of somatic mutations in chinese patients with aldosterone-producing adenoma. Hypertension in press.","DOI":"10.1161\/HYPERTENSIONAHA.114.03346"},{"key":"10.1016\/j.coph.2014.12.005_bib0040","doi-asserted-by":"crossref","first-page":"E1341","DOI":"10.1210\/jc.2013-4255","article-title":"Adrenal nodularity and somatic mutations in primary aldosteronism: one node is the culprit?","volume":"99","author":"Dekkers","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.coph.2014.12.005_sbref0045","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1210\/en.2011-1733","article-title":"Potassium channel mutant KCNJ5 T158A expression in HAC-15 cells increases aldosterone synthesis","volume":"153","author":"Oki","year":"2012","journal-title":"Endocrinology"},{"key":"10.1016\/j.coph.2014.12.005_sbref0050","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1073\/pnas.1121407109","article-title":"Hypertension with or without adrenal hyperplasia due to different inherited mutations in the potassium channel KCNJ5","volume":"109","author":"Scholl","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coph.2014.12.005_bib0055","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1161\/HYPERTENSIONAHA.111.183996","article-title":"KCNJ5 mutations in European families with nonglucocorticoid remediable familial hyperaldosteronism","volume":"59","author":"Mulatero","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.coph.2014.12.005_sbref0060","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1161\/HYPERTENSIONAHA.111.188532","article-title":"Visinin-like 1 is upregulated in aldosterone-producing adenomas with KCNJ5 mutations and protects from calcium-induced apoptosis","volume":"59","author":"Williams","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.coph.2014.12.005_bib0065","doi-asserted-by":"crossref","first-page":"e41926","DOI":"10.1371\/journal.pone.0041926","article-title":"Comprehensive re-sequencing of adrenal aldosterone producing lesions reveal three somatic mutations near the KCNJ5 potassium channel selectivity filter","volume":"7","author":"Akerstrom","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.coph.2014.12.005_bib0070","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1161\/HYPERTENSIONAHA.111.186239","article-title":"Somatic mutations affecting the selectivity filter of KCNJ5 are frequent in 2 large unselected collections of adrenal aldosteronomas","volume":"59","author":"Azizan","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.coph.2014.12.005_bib0075","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1161\/HYPERTENSIONAHA.111.186478","article-title":"Prevalence, clinical, and molecular correlates of KCNJ5 mutations in primary aldosteronism","volume":"59","author":"Boulkroun","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.coph.2014.12.005_bib0080","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1210\/jc.2011-2885","article-title":"Expression and mutations of KCNJ5 mRNA in Japanese patients with aldosterone-producing adenomas","volume":"97","author":"Taguchi","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.coph.2014.12.005_bib0085","doi-asserted-by":"crossref","first-page":"E819","DOI":"10.1210\/jc.2011-2965","article-title":"Microarray, qPCR, and KCNJ5 sequencing of aldosterone-producing adenomas reveal differences in genotype and phenotype between zona glomerulosa- and zona fasciculata-like tumors","volume":"97","author":"Azizan","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.coph.2014.12.005_sbref0090","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/ng.2716","article-title":"Somatic mutations in ATP1A1 and CACNA1D underlie a common subtype of adrenal hypertension","volume":"45","author":"Azizan","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.coph.2014.12.005_sbref0095","doi-asserted-by":"crossref","DOI":"10.1038\/ng.2550","article-title":"Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension","volume":"45","author":"Beuschlein","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.coph.2014.12.005_sbref0100","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1038\/ng.2695","article-title":"Somatic and germline CACNA1D calcium channel mutations in aldosterone-producing adenomas and primary aldosteronism","volume":"45","author":"Scholl","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.coph.2014.12.005_bib0105","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1161\/HYPERTENSIONAHA.114.03419","article-title":"Genetic spectrum and clinical correlates of somatic mutations in aldosterone-producing adenoma","volume":"64","author":"Fernandes-Rosa","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.coph.2014.12.005_bib0110","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1152\/physrev.00030.2003","article-title":"Control of aldosterone secretion: a model for convergence in cellular signaling pathways","volume":"84","author":"Spat","year":"2004","journal-title":"Physiol Rev"},{"key":"10.1016\/j.coph.2014.12.005_bib0115","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.tips.2008.07.013","article-title":"Emerging roles for two-pore-domain potassium channels and their potential therapeutic impact","volume":"29","author":"Bayliss","year":"2008","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.coph.2014.12.005_bib0120","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1073\/pnas.0712000105","article-title":"TASK channel deletion in mice causes primary hyperaldosteronism","volume":"105","author":"Davies","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coph.2014.12.005_bib0125","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/sj.emboj.7601934","article-title":"Invalidation of TASK1 potassium channels disrupts adrenal gland zonation and mineralocorticoid homeostasis","volume":"27","author":"Heitzmann","year":"2008","journal-title":"EMBO J"},{"key":"10.1016\/j.coph.2014.12.005_bib0130","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1161\/HYPERTENSIONAHA.111.189662","article-title":"TASK-3 channel deletion in mice recapitulates low-renin essential hypertension","volume":"59","author":"Guagliardo","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.coph.2014.12.005_bib0135","doi-asserted-by":"crossref","first-page":"4740","DOI":"10.1210\/en.2012-1527","article-title":"Task3 potassium channel gene invalidation causes low renin and salt-sensitive arterial hypertension","volume":"153","author":"Penton","year":"2012","journal-title":"Endocrinology"},{"key":"10.1016\/j.coph.2014.12.005_bib0140","doi-asserted-by":"crossref","DOI":"10.1210\/en.2013-1101","article-title":"Severe hyperaldosteronism in neonatal Task3 potassium channel knockout mice is associated with activation of the intra-adrenal renin\u2013angiotensin system","author":"Bandulik","year":"2013","journal-title":"Endocrinology"},{"key":"10.1016\/j.coph.2014.12.005_bib0145","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1365-2265.2009.03738.x","article-title":"The role of TASK1 in aldosterone production and its expression in normal adrenal and aldosterone-producing adenomas","volume":"73","author":"Nogueira","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.coph.2014.12.005_bib0150","doi-asserted-by":"crossref","first-page":"E674","DOI":"10.1210\/jc.2013-2900","article-title":"Lower expression of the TWIK-related acid-sensitive K+ channel 2 (TASK-2) gene is a hallmark of aldosterone-producing adenoma causing human primary aldosteronism","volume":"99","author":"Lenzini","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.coph.2014.12.005_bib0155","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1161\/HYPERTENSIONAHA.107.100438","article-title":"Heterogeneity of aldosterone-producing adenomas revealed by a whole transcriptome analysis","volume":"50","author":"Lenzini","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.coph.2014.12.005_bib0160","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1161\/HYPERTENSIONAHA.111.173948","article-title":"Primary hyperparathyroidism with concurrent primary aldosteronism","volume":"58","author":"Maniero","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.coph.2014.12.005_bib0165","doi-asserted-by":"crossref","first-page":"E75","DOI":"10.1210\/jc.2011-2183","article-title":"Hyperparathyroidism in patients with primary aldosteronism: cross-sectional and interventional data from the GECOH study","volume":"97","author":"Pilz","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.coph.2014.12.005_bib0170","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1161\/HYPERTENSIONAHA.112.195891","article-title":"Hyperparathyroidism can be useful in the identification of primary aldosteronism due to aldosterone-producing adenoma","volume":"60","author":"Rossi","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.coph.2014.12.005_bib0175","doi-asserted-by":"crossref","first-page":"E209","DOI":"10.1152\/ajpendo.2001.280.2.E209","article-title":"PTH and PTH-related peptide enhance steroid secretion from human adrenocortical cells","volume":"280","author":"Mazzocchi","year":"2001","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.coph.2014.12.005_bib0180","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1161\/HYPERTENSIONAHA.112.202945","article-title":"Elevation of angiotensin-II type-1-receptor autoantibodies titer in primary aldosteronism as a result of aldosterone-producing adenoma","volume":"61","author":"Rossitto","year":"2013","journal-title":"Hypertension"},{"key":"10.1016\/j.coph.2014.12.005_bib0185","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/0039-128X(94)00022-5","article-title":"Type 1 angiotensin II receptors of adrenal tumors","volume":"60","author":"Nawata","year":"1995","journal-title":"Steroids"},{"key":"10.1016\/j.coph.2014.12.005_bib0190","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3109\/07435809509030434","article-title":"Expression of type 1 angiotensin II receptors in human aldosteronomas","volume":"21","author":"Sarzani","year":"1995","journal-title":"Endocr Res"},{"key":"10.1016\/j.coph.2014.12.005_bib0195","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1080\/07435809609043718","article-title":"Angiotensin II receptors in the human adrenal gland","volume":"22","author":"Breault","year":"1996","journal-title":"Endocr Res"},{"key":"10.1016\/j.coph.2014.12.005_bib0200","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/nrendo.2011.180","article-title":"A diagnostic algorithm\u2014the holy grail of primary aldosteronism","volume":"7","author":"Rossi","year":"2011","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.coph.2014.12.005_bib0205","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1210\/jc.2013-3282","article-title":"Autoimmune mechanisms activating the angiotensin AT1 receptor in \u2018primary\u2019 aldosteronism","volume":"99","author":"Kem","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.coph.2014.12.005_bib0210","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1093\/hmg\/ddq029","article-title":"Constitutive beta-catenin activation induces adrenal hyperplasia and promotes adrenal cancer development","volume":"19","author":"Berthon","year":"2010","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.coph.2014.12.005_bib0215","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1093\/hmg\/ddt484","article-title":"WNT\/beta-catenin signalling is activated in aldosterone-producing adenomas and controls aldosterone production","volume":"23","author":"Berthon","year":"2014","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.coph.2014.12.005_bib0220","first-page":"1","article-title":"Non-tumorous \u201cprimary\u201d aldosteronism. I. Type relieved by glucocorticoid (glucocorticoid-remediable aldosteronism)","volume":"101","author":"Salti","year":"1969","journal-title":"Can Med Assoc J"},{"key":"10.1016\/j.coph.2014.12.005_bib0225","first-page":"1109","article-title":"Hypertension, increased aldosterone secretion and low plasma renin activity relieved by dexamethasone","volume":"95","author":"Sutherland","year":"1966","journal-title":"Can Med Assoc J"},{"key":"10.1016\/j.coph.2014.12.005_bib0230","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/355262a0","article-title":"A chimaeric 11 beta-hydroxylase\/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension","volume":"355","author":"Lifton","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.coph.2014.12.005_bib0235","doi-asserted-by":"crossref","first-page":"4328","DOI":"10.1210\/jcem.83.12.5309","article-title":"Rapid diagnosis and identification of cross-over sites in patients with glucocorticoid remediable aldosteronism","volume":"83","author":"MacConnachie","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.coph.2014.12.005_bib0240","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1159\/000360870","article-title":"Genetics of primary aldosteronism","volume":"43","author":"Funder","year":"2014","journal-title":"Front Horm Res"},{"key":"10.1016\/j.coph.2014.12.005_bib0245","first-page":"3214","article-title":"Familial hyperaldosteronism type II: description of a large kindred and exclusion of the aldosterone synthase (CYP11B2) gene","volume":"83","author":"Torpy","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.coph.2014.12.005_bib0250","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1440-1681.1992.tb00462.x","article-title":"Familial hyperaldosteronism type II: five families with a new variety of primary aldosteronism","volume":"19","author":"Stowasser","year":"1992","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.coph.2014.12.005_bib0255","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1136\/jmg.37.11.831","article-title":"A novel genetic locus for low renin hypertension: familial hyperaldosteronism type II maps to chromosome 7 (7p22)","volume":"37","author":"Lafferty","year":"2000","journal-title":"J Med Genet"},{"key":"10.1016\/j.coph.2014.12.005_bib0260","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/jhh.2010.93","article-title":"Further study of chromosome 7p22 to identify the molecular basis of familial hyperaldosteronism type II","volume":"25","author":"Carss","year":"2011","journal-title":"J Hum Hypertens"},{"key":"10.1016\/j.coph.2014.12.005_bib0265","doi-asserted-by":"crossref","first-page":"E1532","DOI":"10.1210\/jc.2012-1334","article-title":"A novel point mutation in the KCNJ5 gene causing primary hyperaldosteronism and early-onset autosomal dominant hypertension","volume":"97","author":"Charmandari","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.coph.2014.12.005_bib0270","doi-asserted-by":"crossref","first-page":"E1861","DOI":"10.1210\/jc.2013-2428","article-title":"a Novel Y152C KCNJ5 mutation responsible for familial hyperaldosteronism type III","volume":"98","author":"Monticone","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.coph.2014.12.005_bib0275","first-page":"jc20143009","article-title":"Novel KCNJ5 mutations in sporadic aldosterone-producing adenoma reduce Kir3.4 membrane abundance","author":"Cheng","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.coph.2014.12.005_bib0280","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.1210\/jc.2008-0251","article-title":"Body mass index predicts plasma aldosterone concentrations in overweight-obese primary hypertensive patients","volume":"93","author":"Rossi","year":"2008","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Current Opinion in Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471489214001726?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471489214001726?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T05:50:54Z","timestamp":1717653054000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471489214001726"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":56,"alternative-id":["S1471489214001726"],"URL":"https:\/\/doi.org\/10.1016\/j.coph.2014.12.005","relation":{},"ISSN":["1471-4892"],"issn-type":[{"value":"1471-4892","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The molecular basis of primary aldosteronism: from chimeric gene to channelopathy","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coph.2014.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}